News
Boxlight Announces Michael Pope as Chairman and CEO
Boxlight Corporation (NASDAQ: BOXL), a leading provider of interactive technology solutions for the global education market, today announced that Michael Pope has been named as its Chairman and
Corona-Aktien kaufen: Heat Biologics ist Geschichte!
Anfang des Monats berichteten wir über den ausgebrochenen Corona-Hype rund um Heat Biologics (WKN: A2JB4Y). Die Firma wurde auch in der Folgezeit nicht müde, die Krise für sich zu nutzen.
Satte 5
ProtoKinetix Files for Patent Protection for AAGP® to be Used in Dry Eye Disease
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) recently filed for patent protection for new applications of its AAGP® molecule.
During recent
Novus Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced financial
Bango Enables Carrier Billing Subscriptions for Hatch Gaming Platform
Bango (AIM: BGO), the mobile commerce company, announces it has launched carrier billing payment services for Hatch, the monthly subscription based 5G games streaming platform. Following an initial
Fuel Tech Reports 2019 Fourth Quarter and Full Year Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
AYRO - Club Car Partnership Announce First Deliveries to Canada and Mexico
AYRO, Inc. (”AYRO” or the “Company”), a designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets
Sonoma Pharmaceuticals: Spektakuläre Coronavirus-News!
Es ist eine News, die aktuell noch so gut wie niemand auf dem Schirm haben dürfte und über deren Bedeutung man sich erst langsam im Klaren werden muss: Sonoma Pharmaceuticals (WKN: A2PMPH) hat aller
Lead Researcher Behind Genprex’s Diabetes Gene Therapy Featured in New Video Interview
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious
Fuel Tech Schedules 2019 Fourth Quarter and Full Year Financial Results and Conference Call
Fuel Tech, Inc. (NASDAQ: FTEK) (or “the Company”), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in
Genprex to Present at the 2020 LD Micro Virtual Conference
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today
Heat Biologics mit +210% in 2 Tagen – dank Corona!
Als einer der meistdiskutierten Werte in unserem Live Chat macht die Aktie von Heat Biologics (WKN: A2JB4Y) aktuell mit einem Höhenflug von +210% innerhalb von nur zwei Tagen auf sich aufmerksam
Novus Therapeutics Completes Enrollment of Phase 2a Trial of OP0201 in Pediatric Patients with Acute Otitis Media
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced that it has
Marko Maras, CEO of Audiens accepted into Forbes Business Council
Marko Maras, CEO of Audiens, a global customer data platform that gives marketers an easy to use audience creation platform, has been accepted into the Forbes Business Council, the foremost growth
Sonoma Pharmaceuticals: Millioneneinnahme und Expansion
Während die Märkte derzeit täglich ein neues Tief markieren und große Werte teilweise Einbußen von mehr als einem Drittel ihrer Marktkapitalisierung über die letzten Wochen verkraften müssen, geht
Diversified Restaurant Holdings, Inc. and ICV Partners Complete Merger
Diversified Restaurant Holdings, Inc. (Nasdaq: SAUC, "DRH" or the "Company") today announced the completion of its previously announced merger with investment entities affiliated with ICV Partners
Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to
ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX) announces the progress of screening PKX-001 for cardiometabolic disorders.
“Using isolated
Genprex, Inc. Prices $17,500,000 Common Stock Offering Priced At-The-Market and Without Warrants
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of the world’s most deadly
Sonoma meldet Rekordergebnis – und arbeitet an „profitablen Transaktionen“
Letzten Monat hatte ich auf die spannende Situation bei Sonoma Pharmaceuticals (WKN: A2PMPH) verwiesen. Die neuesten Quartalszahlen sind besser als erwartet. Das kurz- und mittelfristige
Mannatech Declares Fourth Quarter 2019 Dividend
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend
Medalist Diversified REIT Prices $4.6 Million Underwritten Public Offering of Series A Preferred Stock
Medalist Diversified REIT, Inc. (Nasdaq: MDRR) (the “Company”), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in
1347 Property Insurance Holdings, Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”) announced today that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred
Palatin: Aktie fällt – wer greift nach dem Sex-Pen?
Im vergangenen Jahr feierten SD-Leser bis zu +600% Kursgewinn mit der Aktie von Palatin Technologies (WKN: A1C538). Wir rieten rechtzeitig zum Ausstieg, bevor der Kurs wieder stark nachgab. Doch
Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious